Skip to main content

Table 5 Issues influencing community pharmacy palliative medicines provision

From: Supporting patient access to medicines in community palliative care: on-line survey of health professionals’ practice, perceived effectiveness and influencing factors

How frequently do you:
  Never Rarely Sometimes Often Always
Undertake medicines optimisation reviews for palliative care patients 61 (28) 65 (30) 52 (24) 26 (12) 13 (6.0)
Feel that lack of awareness of patients’ palliative status influences your ability to help patients access medicines 13 (6.0) 22 (10) 71 (33) 87 (40) 25 (11)
Encounter a discrepancy between palliative care medicines prescribed and the stock you hold 12 (5.5) 36 (17) 76 (35) 79 (36) 14 (6.5)
Limit your stock of palliative care medicines because ‘use by’ dates are likely to expire 27 (12) 37 (17) 47 (22) 67 (31) 40 (18)
Limit your stock of palliative care medicines because of lack of storage space 63 (29) 59 (27) 38 (18) 41 (19) 15 (6.9)
Experience problems receiving prescriptions electronically from patients’ GP practices 28 (13) 40 (18) 65 (30) 51 (23) 34 (16)
Encounter carers not having satisfactory ID, seeking to collect Controlled Drug prescriptions for patients 16 (7.3) 68 (31) 73 (33) 51 (23) 10 (4.6)
  1. Responses range n = 215 to n = 217